Carcinoid heart disease are rare neuroendocrine malignancy with an incidence of 5.1/100,000/year, occurring mainly in the gastrointestinal tract (67.5%) followed by the Broncho pulmonary system (25.3%) and occurs when large amounts of vasoactive substances such as serotonin, tachykinins, and prostaglandins reach the right side of the heart.
(2024). A Rare Presentation of Carcinoid Heart Disease Secondary to a Thyroid Neuroendocrine Tumor. Cardiovascular Research Prove Journal, 8(2), -. doi: 10.21608/cvrepj.2024.400100
MLA
. "A Rare Presentation of Carcinoid Heart Disease Secondary to a Thyroid Neuroendocrine Tumor", Cardiovascular Research Prove Journal, 8, 2, 2024, -. doi: 10.21608/cvrepj.2024.400100
HARVARD
(2024). 'A Rare Presentation of Carcinoid Heart Disease Secondary to a Thyroid Neuroendocrine Tumor', Cardiovascular Research Prove Journal, 8(2), pp. -. doi: 10.21608/cvrepj.2024.400100
VANCOUVER
A Rare Presentation of Carcinoid Heart Disease Secondary to a Thyroid Neuroendocrine Tumor. Cardiovascular Research Prove Journal, 2024; 8(2): -. doi: 10.21608/cvrepj.2024.400100
)
View on SCiNiTO